
vaccines
-
-
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines
How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing?
Read more: How Can Policymakers Overcome the Hurdles to Scaling up Antibody Manufacturing? -
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines
Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19?
Read more: Why Aren’t Therapeutic Antibodies Being Used More to Treat COVID-19? -
Contributors FDA Health Law Policy Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Vaccines
What Can Policymakers Learn from the Slow COVID-19 Vaccine Rollout?
Read more: What Can Policymakers Learn from the Slow COVID-19 Vaccine Rollout? -
COVID and the Law FDA Health Law Policy Human Subjects Research Patient Care Pharmaceuticals Public Health Scientific Evidence Vaccines
From 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization
Read more: From 9/11 to COVID-19: A Brief History of FDA Emergency Use Authorization -
Bioethics Biospecimens Immunization Population-Level Bioethics Privacy Public Health Shelly Simana Transparency Vaccines
Is Israel Trading Medical Information for Vaccines? Ethical and Legal Considerations
Read more: Is Israel Trading Medical Information for Vaccines? Ethical and Legal Considerations -
Contributors FDA Health Law Policy Human Subjects Research Jacob Sherkow Nicholson Price Patient Care Pharmaceuticals Public Health Rachel Sachs Scientific Evidence Vaccines
How Can Policymakers Encourage COVID-19 Vaccine Trials for Children?
Read more: How Can Policymakers Encourage COVID-19 Vaccine Trials for Children?